SEC Filing - TriSalus Life Sciences, Inc.

View:

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Magnetar Financial LLC

(Last)

(First)

(Middle)

1603 ORRINGTON AVENUE

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MedTech Acquisition Corp [ MTAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Rule 10b5-1(c) Transaction Indication

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		67,992	D	$10.4861	0	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		107,904	D	$10.4861	0	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁵⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		27,891	D	$10.4861	3	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		21,887	D	$10.4861	1	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁷⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		16,032	D	$10.4861	52,275	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁸⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		85,137	D	$10.4861	0	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁹⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		33,227	D	$10.4861	108,343	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹⁰⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		38,079	D	$10.4861	1	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		42,567	D	$10.4861	0	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹²⁾
Class A Common Stock	06/12/2023		J⁽¹⁴⁾		5,112	D	$10.4861	16,668	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹³⁾
Class A Common Stock								391,047	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁶⁾
Class A Common Stock								131,667	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾⁽¹¹⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

Magnetar Financial LLC

(Last)

(First)

(Middle)

1603 ORRINGTON AVENUE

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Magnetar Capital Partners LP

(Last)

(First)

(Middle)

1603 ORRINGTON AVENUE

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Supernova Management LLC

(Last)

(First)

(Middle)

1603 ORRINGTON AVENUE

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Snyderman David J.

(Last)

(First)

(Middle)

1603 ORRINGTON AVENUE

13TH FLOOR

(Street)

EVANSTON

60201

(City)

(State)

(Zip)

Explanation of Responses:

1. Magnetar Financial LLC ("Magnetar Financial") serves as investment manager of each of (1) Magnetar Constellation Fund II Ltd, Magnetar Constellation Master Fund, Ltd, Magnetar Healthcare Master Fund Ltd, Magnetar SC Fund Ltd, Magnetar Xing He Master Fund Ltd, and Purpose Alternative Credit Fund Ltd, all of which are Cayman Islands exempted companies, (2) Magnetar Structured Credit Fund, LP, a Delaware limited partnership, (3) Magnetar Lake Credit Fund LLC and Purpose Alternative Credit Fund - T LLC, all of which are Delaware limited liability companies, and (4) three separately managed accounts (collectively, the "Magnetar Funds").

2. Magnetar Capital Partners LP ("Magnetar Capital Partners"), a Delaware limited partnership, is the sole member and parent holding company of Magnetar Financial. Supernova Management LLC ("Supernova Management"), a Delaware limited liability company, is the general partner of Magnetar Capital Partners. The manager of Supernova Management is David J. Snyderman, a citizen of the United States of America.

3. Each of the Magnetar Funds, Magnetar Financial, Magnetar Capital Partners, Supernova Management and David J. Snyderman disclaims beneficial ownership of these shares of the Issuer's Class A Common Stock.

4. These securities are held directly for a separately managed account.

5. These securities are held directly by Magnetar Constellation Fund II, Ltd.

6. These securities are held directly by Magnetar Constellation Master Fund, Ltd.

7. These securities are held directly by Magnetar Healthcare Master Fund Ltd.

8. These securities are held directly by Magnetar Lake Credit Fund LLC.

9. These securities are held directly by Magnetar SC Fund Ltd.

10. These securities are held directly by Magnetar Structured Credit Fund, LP.

11. These securities are held directly by Magnetar Xing He Master Fund Ltd.

12. These securities are held directly by Purpose Alternative Credit Fund Ltd.

13. These securities are held directly by Purpose Alternative Credit Fund - T LLC.

14. The Reporting Persons elected to redeem these shares of the Issuer's Class A Common Stock for cash in connection with the Issuer's special meeting of stockholders on June 12, 2023.

Remarks:

A joint filing agreement was filed as Exhibit 99.1 to the Form 3 jointly filed with the SEC by the Reporting Persons on December 22, 2022, and is incorporated herein by reference.

	/s/ Hayley A. Stein, Attorney-in-Fact for David J. Snyderman, as Manager of Supernova Management LLC, which is the General Partner of Magnetar Capital Partners LP, which is in turn the Sole Member of Magnetar Financial LLC	06/14/2023
	/s/ Hayley A. Stein, Attorney-in-Fact for David J. Snyderman, as Manager of Supernova Management LLC, which is the General Partner of Magnetar Capital Partners LP	06/14/2023
	/s/ Hayley A. Stein, Attorney-in-Fact for David J. Snyderman, as Manager of Supernova Management LLC	06/14/2023
	/s/ Hayley A. Stein, Attorney-in-Fact for David J. Snyderman	06/14/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.